share_log

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RYAN ARTHUR F

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RYAN ARTHUR F

再生元制药公司 | 4：持股变动声明-董事 RYAN ARTHUR F
美股SEC公告 ·  01/06 16:15

Moomoo AI 已提取核心信息

On January 2, 2025, RYAN ARTHUR F, an executive at Regeneron Pharmaceuticals, was granted 166 shares of Common Stock at $0 per share. This transaction was reported as a direct acquisition under the transaction code 'A', indicating a grant, award, or other acquisition.Following this transaction, RYAN ARTHUR F's direct ownership of Regeneron Pharmaceuticals Common Stock increased to 17,748 shares. The acquisition was completed on the reported date, with no additional transactions mentioned in the filing.
On January 2, 2025, RYAN ARTHUR F, an executive at Regeneron Pharmaceuticals, was granted 166 shares of Common Stock at $0 per share. This transaction was reported as a direct acquisition under the transaction code 'A', indicating a grant, award, or other acquisition.Following this transaction, RYAN ARTHUR F's direct ownership of Regeneron Pharmaceuticals Common Stock increased to 17,748 shares. The acquisition was completed on the reported date, with no additional transactions mentioned in the filing.
2025年1月2日，再生元制药公司的高管RYAN ARTHUR F获得了166股普通股，价格为每股0美元。该交易被报告为直接收购，交易代码为'A'，表示授予、奖励或其他收购。在此次交易之后，RYAN ARTHUR F对再生元制药公司的普通股直接持有量增加至17,748股。收购在报告日期完成，申报中没有提到其他交易。
2025年1月2日，再生元制药公司的高管RYAN ARTHUR F获得了166股普通股，价格为每股0美元。该交易被报告为直接收购，交易代码为'A'，表示授予、奖励或其他收购。在此次交易之后，RYAN ARTHUR F对再生元制药公司的普通股直接持有量增加至17,748股。收购在报告日期完成，申报中没有提到其他交易。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Dogwood Therapeutics
    DWTX
    -- 23.776
    Hepion Pharmaceuticals
    HEPA
    -- 0.2200
    Nutriband
    NTRB
    -- 11.100
    Transcode Therapeutics
    RNAZ
    -- 4.500
    Unity Biotechnology
    UBX
    -- 2.6600
    解锁完整榜单
    热门讨论
    特朗普2.0时代开启，全球股市新风口在哪里？
    ▪️加密货币政策能否利好crypto？ ▪️关税政策能否利好中概等海外资产？ ▪️在特朗普政策下，有哪些投资机会值得关注？ 展开
    离川普上台只有7天了～
    热门中概股
    追踪最热门的中概股实时资讯。